Suppr超能文献

托纳贝萨特(SB - 220453)是一种具有抗惊厥特性的新型苯并吡喃,可减弱三叉神经诱导的神经血管反射。

Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes.

作者信息

Parsons A A, Bingham S, Raval P, Read S, Thompson M, Upton N

机构信息

Neurosciences Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex CM19 5AW.

出版信息

Br J Pharmacol. 2001 Apr;132(7):1549-57. doi: 10.1038/sj.bjp.0703932.

Abstract
  1. The effects of tonabersat (SB-220453) were evaluated on trigeminal nerve ganglion stimulation-induced sensory-autonomic neurovascular reflexes in the anaesthetized cat. Comparisons were made to intravenous administration of carabersat (SB-204269), and to valproate, gabapentin and lamotrigine following intraduodenal administration. 2. There were no effects on resting blood pressure, heart rate, carotid blood flow or carotid vascular resistance for any compound evaluated. 3. Trigeminal nerve ganglion stimulation increased carotid blood flow by 65% and reduced vascular resistance by 41% with minimal effect on blood pressure (< 10%) and no effect on heart rate. Intravenous infusion of tonabersat or carabersat (both 3.4 micromol h(-1)) produced time related reductions in stimulation-induced responses with a maximal inhibition (relative to control) of 30 +/- 7% (n=4), at 240 min for tonabersat and 33+/-4% (n=3) at 180 min for carabersat. Tonabersat (11.5 micromol h(-1)) produced a similar inhibitory effect (32 +/- 9%, n=4) after 120 min of infusion. 4. Following intraduodenal administration of tonabersat, the maximal inhibition of nerve stimulation-induced responses was 55 +/- 4% at 120 min (n=4) for tonabersat 10 mg kg(-1), and 24+/-2% after 180 min for 1 mg kg(-1) (n=4). 5. Intraduodenal administration of sodium valproate (10 or 100 mg kg(-1) n=4/group) had no effect on neurovascular reflexes. Maximal inhibition of nerve ganglion-stimulated reductions in carotid vascular resistance were observed at 150 min for lamotrigine (50 mg kg(-1), 52+/-12%, n=4) and gabapentin (100 mg kg(-1), 17+/-13%, n=3). Lamotrigine 10 mg kg(-1) produced 22+/-11% (n=3) inhibition after 180 min. 6. These data demonstrate blockade of trigeminal parasympathetic reflexes with tonabersat, carabersat and other anticonvulsants. These agents may therefore have therapeutic benefit in conditions where this type of reflex is evident.
摘要
  1. 在麻醉猫中,评估了托纳贝萨特(SB - 220453)对三叉神经节刺激诱发的感觉 - 自主神经血管反射的影响。将其与静脉注射卡拉贝萨特(SB - 204269)以及十二指肠内给药后的丙戊酸盐、加巴喷丁和拉莫三嗪进行了比较。2. 对于所评估的任何化合物,对静息血压、心率、颈动脉血流量或颈动脉血管阻力均无影响。3. 三叉神经节刺激使颈动脉血流量增加65%,血管阻力降低41%,对血压影响极小(<10%),对心率无影响。静脉输注托纳贝萨特或卡拉贝萨特(均为3.4 μmol h⁻¹)可使刺激诱发的反应随时间降低,托纳贝萨特在240分钟时最大抑制率(相对于对照)为30±7%(n = 4),卡拉贝萨特在180分钟时为33±4%(n = 3)。托纳贝萨特(11.5 μmol h⁻¹)输注120分钟后产生类似的抑制作用(32±9%,n = 4)。4. 十二指肠内给予托纳贝萨特后,对于10 mg kg⁻¹的托纳贝萨特,在120分钟时神经刺激诱发反应的最大抑制率为55±4%(n = 4),对于1 mg kg⁻¹的托纳贝萨特,在180分钟后为24±2%(n = 4)。5. 十二指肠内给予丙戊酸钠(10或100 mg kg⁻¹,每组n = 4)对神经血管反射无影响。拉莫三嗪(50 mg kg⁻¹)在150分钟时观察到对神经节刺激引起的颈动脉血管阻力降低的最大抑制率为52±12%(n = 4),加巴喷丁(100 mg kg⁻¹)为17±13%(n = 3)。10 mg kg⁻¹的拉莫三嗪在180分钟后产生22±11%(n = 3)的抑制作用。6. 这些数据表明托纳贝萨特、卡拉贝萨特和其他抗惊厥药可阻断三叉神经副交感反射。因此,这些药物在这种类型反射明显的病症中可能具有治疗益处。

相似文献

10
[Effect of adrenaline on vagus nerve reflexes].[肾上腺素对迷走神经反射的影响]
Nihon Jibiinkoka Gakkai Kaiho. 1999 Jul;102(7):891-7. doi: 10.3950/jibiinkoka.102.891.

引用本文的文献

5
Pharmacology.药理学
Handb Clin Neurol. 2010;97:47-71. doi: 10.1016/S0072-9752(10)97004-8.
6
New drugs for migraine.偏头痛新药。
J Headache Pain. 2009 Dec;10(6):395-406. doi: 10.1007/s10194-009-0156-9. Epub 2009 Oct 1.
9
Molecular targets for antiepileptic drug development.抗癫痫药物研发的分子靶点
Neurotherapeutics. 2007 Jan;4(1):18-61. doi: 10.1016/j.nurt.2006.11.010.
10
Prophylactic migraine therapy: emerging treatment options.预防性偏头痛治疗:新兴的治疗选择。
Curr Pain Headache Rep. 2004 Jun;8(3):178-84. doi: 10.1007/s11916-004-0049-1.

本文引用的文献

5
Nonepileptic uses of gabapentin.加巴喷丁的非癫痫用途。
Epilepsia. 1999;40 Suppl 6:S66-72; discussion S73-4. doi: 10.1111/j.1528-1157.1999.tb00936.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验